PortfoliosLab logoPortfoliosLab logo
GDRX vs. HIMS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GDRX vs. HIMS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GoodRx Holdings, Inc. (GDRX) and Hims & Hers Health, Inc. (HIMS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GDRX achieves a 8.86% return, which is significantly higher than HIMS's -15.28% return.


GDRX

1D
-4.22%
1M
15.69%
YTD
8.86%
6M
10.07%
1Y
-22.77%
3Y*
-18.20%
5Y*
-40.22%
10Y*

HIMS

1D
-0.90%
1M
0.36%
YTD
-15.28%
6M
-24.24%
1Y
-51.54%
3Y*
45.13%
5Y*
14.56%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

GDRX vs. HIMS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
GDRX
GoodRx Holdings, Inc.
8.86%-41.72%-30.60%43.78%-85.74%-18.99%-20.12%
HIMS
Hims & Hers Health, Inc.
-15.28%34.28%171.69%38.85%-2.14%-55.14%35.56%

Correlation

The correlation between GDRX and HIMS is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.29

Correlation (3Y)
Calculated over the trailing 3-year period

0.27

Correlation (5Y)
Calculated over the trailing 5-year period

0.35

Correlation (All Time)
Calculated using the full available price history since Sep 24, 2020

0.33

Fundamentals

Market Cap

GDRX:

$1.01B

HIMS:

$6.28B

EPS

GDRX:

$0.09

HIMS:

-$0.05

PS Ratio

GDRX:

1.30

HIMS:

2.85

PB Ratio

GDRX:

1.62

HIMS:

14.08

Total Revenue (TTM)

GDRX:

$787.89M

HIMS:

$2.37B

Gross Profit (TTM)

GDRX:

$638.38M

HIMS:

$1.70B

EBITDA (TTM)

GDRX:

$153.80M

HIMS:

$16.04M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GDRX vs. HIMS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GDRX
GDRX Risk / Return Rank: 2929
Overall Rank
GDRX Sharpe Ratio Rank: 2727
Sharpe Ratio Rank
GDRX Sortino Ratio Rank: 3030
Sortino Ratio Rank
GDRX Omega Ratio Rank: 3030
Omega Ratio Rank
GDRX Calmar Ratio Rank: 2727
Calmar Ratio Rank
GDRX Martin Ratio Rank: 2929
Martin Ratio Rank

HIMS
HIMS Risk / Return Rank: 1818
Overall Rank
HIMS Sharpe Ratio Rank: 1717
Sharpe Ratio Rank
HIMS Sortino Ratio Rank: 2121
Sortino Ratio Rank
HIMS Omega Ratio Rank: 2121
Omega Ratio Rank
HIMS Calmar Ratio Rank: 1616
Calmar Ratio Rank
HIMS Martin Ratio Rank: 1717
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GDRX vs. HIMS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for GoodRx Holdings, Inc. (GDRX) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GDRXHIMSDifference

Sharpe ratio

Return per unit of total volatility

-0.31

-0.54

+0.23

Sortino ratio

Return per unit of downside risk

0.01

-0.41

+0.42

Omega ratio

Gain probability vs. loss probability

1.00

0.95

+0.05

Calmar ratio

Return relative to maximum drawdown

-0.39

-0.66

+0.27

Martin ratio

Return relative to average drawdown

-0.62

-1.09

+0.48

GDRX vs. HIMS - Sharpe Ratio Comparison

The current GDRX Sharpe Ratio is -0.31, which is higher than the HIMS Sharpe Ratio of -0.54. The chart below compares the historical Sharpe Ratios of GDRX and HIMS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


GDRXHIMSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.31

-0.54

+0.23

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.55

0.18

-0.73

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.54

0.22

-0.76

Drawdowns

GDRX vs. HIMS - Drawdown Comparison

The maximum GDRX drawdown since its inception was -96.73%, which is greater than HIMS's maximum drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for GDRX and HIMS.


Loading charts...

Drawdown Indicators


GDRXHIMSDifference

Max Drawdown

Largest peak-to-trough decline

-96.73%

-87.29%

-9.44%

Max Drawdown (1Y)

Largest decline over 1 year

-63.48%

-78.06%

+14.58%

Max Drawdown (3Y)

Largest decline over 3 years

-79.76%

-78.88%

-0.88%

Max Drawdown (5Y)

Largest decline over 5 years

-96.03%

-79.74%

-16.29%

Current Drawdown

Current decline from peak

-94.84%

-59.98%

-34.86%

Average Drawdown

Average peak-to-trough decline

-74.91%

-43.18%

-31.73%

Ulcer Index

Depth and duration of drawdowns from previous peaks

40.20%

46.94%

-6.74%

Volatility

GDRX vs. HIMS - Volatility Comparison

The current volatility for GoodRx Holdings, Inc. (GDRX) is 17.74%, while Hims & Hers Health, Inc. (HIMS) has a volatility of 25.84%. This indicates that GDRX experiences smaller price fluctuations and is considered to be less risky than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GDRXHIMSDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.74%

25.84%

-8.10%

Volatility (6M)

Calculated over the trailing 6-month period

45.63%

66.81%

-21.18%

Volatility (1Y)

Calculated over the trailing 1-year period

73.94%

95.97%

-22.03%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

72.90%

83.37%

-10.47%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

72.48%

77.22%

-4.74%

Dividends

GDRX vs. HIMS - Dividend Comparison

Neither GDRX nor HIMS has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

GDRX vs. HIMS - Financials Comparison

This section allows you to compare key financial metrics between GoodRx Holdings, Inc. and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00M200.00M300.00M400.00M500.00M600.00M20222023202420252026
194.01M
608.10M
(GDRX) Total Revenue
(HIMS) Total Revenue
Values in USD except per share items

GDRX vs. HIMS - Profitability Comparison

The chart below illustrates the profitability comparison between GoodRx Holdings, Inc. and Hims & Hers Health, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%70.0%80.0%90.0%20222023202420252026
89.6%
65.3%
Portfolio components
GDRX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, GoodRx Holdings, Inc. reported a gross profit of 173.85M and revenue of 194.01M. Therefore, the gross margin over that period was 89.6%.

HIMS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a gross profit of 396.79M and revenue of 608.10M. Therefore, the gross margin over that period was 65.3%.

GDRX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, GoodRx Holdings, Inc. reported an operating income of 14.01M and revenue of 194.01M, resulting in an operating margin of 7.2%.

HIMS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported an operating income of -78.32M and revenue of 608.10M, resulting in an operating margin of -12.9%.

GDRX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, GoodRx Holdings, Inc. reported a net income of 10.11M and revenue of 194.01M, resulting in a net margin of 5.2%.

HIMS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a net income of -92.12M and revenue of 608.10M, resulting in a net margin of -15.2%.


Frequently Asked Questions


GDRX and HIMS have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HIMS has higher volatility (25.84%) compared to GDRX (17.74%). In terms of maximum drawdown, GDRX dropped -96.73% vs HIMS's -87.29%.

GDRX currently has the higher Sharpe Ratio (-0.31 vs -0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GDRX and HIMS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer